NIH reports preliminary mix-and-match vaccine data


An NIH study that included over 450 adults who had been vaccinated against COVID-19 found that people who were given Johnson & Johnson's vaccine had a more durable immune response when they received a booster shot from either Moderna or Pfizer/BioNTech. The preliminary results still need to undergo peer review but could factor into a decision on J&J's request for authorization of the company's own COVID-19 vaccine as a booster.

Full story:

AANP SmartBrief

Top health care stories for nurse practitioners

Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues.